Joincare Pharmaceutical Group Industry | Sustainability Performance
Develops, manufactures, and markets pharmaceutical products, including biopharmaceuticals and generic medicines, serving domestic and international markets.
1992
China
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8664
Overallⓘ#474
in Chinaⓘ#208
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Joincare Pharmaceutical Group Industry Co Ltd, Chinese pharma, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of multiple drug product quality at Joincare production facilities, plus periodic Chinese SAMR enforcement scrutiny on alleged inadequate disclosure affecting Chinese institutional minority shareholders amid Chinese pharma market normalization.
